INCYTE CORPORATION Increase (Decrease) in Accounts Receivable
INCYTE CORPORATION (INCY) reported Increase (Decrease) in Accounts Receivable of $27.03 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-04-28
- INCYTE CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $27.03M.
- INCYTE CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $128.50M, a 32.89% increase year-over-year.
- INCYTE CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $53.00M, a 173.20% increase year-over-year.
- INCYTE CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $20.23M.
- INCYTE CORPORATION increase (decrease) in accounts receivable for fiscal 2025 was $170.77M, a 53.04% increase from fiscal 2024.
- INCYTE CORPORATION increase (decrease) in accounts receivable for fiscal 2024 was $111.59M, a 13.08% increase from fiscal 2023.
- INCYTE CORPORATION increase (decrease) in accounts receivable for fiscal 2023 was $98.68M, a 245.28% increase from fiscal 2022.
- INCYTE CORPORATION increase (decrease) in accounts receivable for fiscal 2022 was $28.58M, a 78.72% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-03-31 | $27.03M 10-Q · filed 2026-04-28 | $155.52M derived: sum of 2 quarters · filed 2026-04-28 | $208.53M derived: sum of 3 quarters · filed 2026-04-28 | $228.75M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $128.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $181.50M derived: sum of 2 quarters · filed 2026-02-10 | $201.73M derived: sum of 3 quarters · filed 2026-02-10 | $170.77M 10-K · filed 2026-02-10 |
| 2025-09-30 | $53.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $73.23M derived: sum of 2 quarters · filed 2025-10-28 | $42.27M 10-Q · filed 2025-10-28 | $138.97M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $20.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$10.73M 10-Q · filed 2025-07-29 | $85.97M derived: sum of 3 quarters · filed 2026-04-28 | $105.37M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | -$30.95M 10-Q · filed 2026-04-28 | $65.74M derived: sum of 2 quarters · filed 2026-04-28 | $85.14M derived: sum of 3 quarters · filed 2026-04-28 | $78.66M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $96.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $116.09M derived: sum of 2 quarters · filed 2026-02-10 | $109.62M derived: sum of 3 quarters · filed 2026-02-10 | $111.59M 10-K · filed 2026-02-10 |
| 2024-09-30 | $19.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $12.92M derived: sum of 2 quarters · filed 2025-10-28 | $14.89M 10-Q · filed 2025-10-28 | $101.19M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$4.51M 10-Q · filed 2025-07-29 | $81.79M derived: sum of 3 quarters · filed 2026-02-10 | $101.06M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $1.97M 10-Q · filed 2025-04-29 | $88.26M derived: sum of 2 quarters · filed 2026-02-10 | $107.53M derived: sum of 3 quarters · filed 2026-02-10 | $121.74M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $86.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $105.56M derived: sum of 2 quarters · filed 2026-02-10 | $119.77M derived: sum of 3 quarters · filed 2026-02-10 | $98.68M 10-K · filed 2026-02-10 |
| 2023-09-30 | $19.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $33.48M derived: sum of 2 quarters · filed 2024-10-29 | $12.38M 10-Q · filed 2024-10-29 | $39.08M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $14.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | -$6.88M 10-Q · filed 2024-07-30 | $19.81M derived: sum of 3 quarters · filed 2025-02-10 | -$44.97M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$21.09M 10-Q · filed 2024-04-30 | $5.60M derived: sum of 2 quarters · filed 2025-02-10 | -$59.18M derived: sum of 3 quarters · filed 2025-02-10 | $61.44M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $26.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$38.09M derived: sum of 2 quarters · filed 2025-02-10 | $82.53M derived: sum of 3 quarters · filed 2025-02-10 | $28.58M 10-K · filed 2025-02-10 |
| 2022-09-30 | -$64.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $55.84M derived: sum of 2 quarters · filed 2023-10-31 | $1.89M 10-Q · filed 2023-10-31 | $101.50M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $120.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $66.67M 10-Q · filed 2023-08-01 | $166.28M derived: sum of 3 quarters · filed 2024-02-13 | $244.80M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | -$53.96M 10-Q · filed 2023-05-02 | $45.66M derived: sum of 2 quarters · filed 2024-02-13 | $124.17M derived: sum of 3 quarters · filed 2024-02-13 | $164.99M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $99.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $178.13M derived: sum of 2 quarters · filed 2024-02-13 | $218.94M derived: sum of 3 quarters · filed 2024-02-13 | $134.31M 10-K · filed 2024-02-13 |
| 2021-09-30 | $78.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $119.33M derived: sum of 2 quarters · filed 2022-11-01 | $34.70M 10-Q · filed 2022-11-01 | $152.22M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $40.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$43.82M 10-Q · filed 2022-08-02 | $73.70M derived: sum of 3 quarters · filed 2023-02-07 | $9.64M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | -$84.64M 10-Q · filed 2022-05-03 | $32.89M derived: sum of 2 quarters · filed 2023-02-07 | -$31.18M derived: sum of 3 quarters · filed 2023-02-07 | $45.84M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $117.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $53.46M derived: sum of 2 quarters · filed 2023-02-07 | $130.47M derived: sum of 3 quarters · filed 2023-02-07 | $173.19M 10-K · filed 2023-02-07 |
| 2020-09-30 | -$64.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $12.94M derived: sum of 2 quarters · filed 2021-11-02 | $55.66M 10-Q · filed 2021-11-02 | $88.35M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $77.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $119.72M 10-Q · filed 2021-08-03 | $152.42M derived: sum of 3 quarters · filed 2022-02-08 | $125.85M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $42.71M 10-Q · filed 2021-05-04 | $75.41M derived: sum of 2 quarters · filed 2022-02-08 | $48.84M derived: sum of 3 quarters · filed 2022-02-08 | $107.44M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $32.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $6.13M derived: sum of 2 quarters · filed 2022-02-08 | $64.73M derived: sum of 3 quarters · filed 2022-02-08 | $1.21M 10-K · filed 2022-02-08 |
| 2019-09-30 | -$26.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $32.03M derived: sum of 2 quarters · filed 2020-11-05 | -$31.48M 10-Q · filed 2020-11-05 | $28.38M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $58.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$4.92M 10-Q · filed 2020-08-04 | $54.94M derived: sum of 3 quarters · filed 2021-02-09 | -$13.63M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$63.52M 10-Q · filed 2020-05-05 | -$3.65M derived: sum of 2 quarters · filed 2021-02-09 | -$72.23M derived: sum of 3 quarters · filed 2021-02-09 | $23.89M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $59.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$8.71M derived: sum of 2 quarters · filed 2021-02-09 | $87.41M derived: sum of 3 quarters · filed 2021-02-09 | $41.30M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$68.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $27.55M derived: sum of 2 quarters · filed 2019-10-29 | -$18.56M 10-Q · filed 2019-10-29 | $49.39M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $96.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $50.01M 10-Q · filed 2019-07-30 | $117.97M derived: sum of 3 quarters · filed 2020-02-13 | $146.79M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$46.11M 10-Q · filed 2019-04-30 | $21.84M derived: sum of 2 quarters · filed 2020-02-13 | $50.67M derived: sum of 3 quarters · filed 2020-02-13 | -$24.79M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $67.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $96.78M derived: sum of 2 quarters · filed 2020-02-13 | $21.32M derived: sum of 3 quarters · filed 2020-02-13 | $117.54M 10-K · filed 2020-02-13 |
| 2017-09-30 | $28.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$46.63M derived: sum of 2 quarters · filed 2018-10-30 | $49.59M 10-Q · filed 2018-10-30 | $66.82M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | -$75.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | $20.76M 10-Q · filed 2018-07-31 | $37.99M derived: sum of 3 quarters · filed 2019-02-14 | $41.89M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $96.22M 10-Q · filed 2018-05-01 | $113.45M derived: sum of 2 quarters · filed 2019-02-14 | $117.35M derived: sum of 3 quarters · filed 2019-02-14 | $133.33M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $17.23M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $21.13M derived: sum of 2 quarters · filed 2019-02-14 | $37.12M derived: sum of 3 quarters · filed 2019-02-14 | $23.95M 10-K · filed 2019-02-14 |
| 2016-09-30 | $3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $19.88M derived: sum of 2 quarters · filed 2017-10-31 | $6.71M 10-Q · filed 2017-10-31 | $34.20M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $15.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $2.82M 10-Q · filed 2017-08-01 | $30.30M derived: sum of 3 quarters · filed 2018-02-15 | $42.15M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | -$13.17M 10-Q · filed 2017-05-04 | $14.31M derived: sum of 2 quarters · filed 2018-02-15 | $26.16M derived: sum of 3 quarters · filed 2018-02-15 | $31.68M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $27.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $39.33M derived: sum of 2 quarters · filed 2018-02-15 | $44.85M derived: sum of 3 quarters · filed 2018-02-15 | $56.52M 10-K · filed 2018-02-15 |
| 2015-09-30 | $11.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $17.36M derived: sum of 2 quarters · filed 2016-11-01 | $29.03M 10-Q · filed 2016-11-01 | -$22.63M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $5.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $17.19M 10-Q · filed 2016-08-09 | -$34.48M derived: sum of 3 quarters · filed 2017-02-14 | $27.92M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $11.67M 10-Q · filed 2016-05-09 | -$39.99M derived: sum of 2 quarters · filed 2017-02-14 | $22.40M derived: sum of 3 quarters · filed 2017-02-14 | $23.21M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | -$51.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $10.73M derived: sum of 2 quarters · filed 2017-02-14 | $11.54M derived: sum of 3 quarters · filed 2017-02-14 | $22.56M 10-K · filed 2017-02-14 |
| 2014-09-30 | $62.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $63.20M derived: sum of 2 quarters · filed 2015-11-03 | $74.22M 10-Q · filed 2015-11-03 | $76.40M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | $811.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $11.83M 10-Q · filed 2015-08-04 | $14.01M derived: sum of 3 quarters · filed 2016-02-12 | $19.68M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | $11.02M 10-Q · filed 2015-04-30 | $13.20M derived: sum of 2 quarters · filed 2016-02-12 | $18.87M derived: sum of 3 quarters · filed 2016-02-12 | $18.35M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $7.85M derived: sum of 2 quarters · filed 2016-02-12 | $7.33M derived: sum of 3 quarters · filed 2016-02-12 | -$35.58M 10-K · filed 2016-02-12 |
| 2013-09-30 | $5.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $5.16M derived: sum of 2 quarters · filed 2014-10-30 | -$37.75M 10-Q · filed 2014-10-30 | $16.66M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | -$519.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$43.43M 10-Q · filed 2014-07-31 | $10.98M derived: sum of 3 quarters · filed 2015-02-17 | $13.68M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | -$42.91M 10-Q · filed 2014-05-01 | $11.50M derived: sum of 2 quarters · filed 2015-02-17 | $14.20M derived: sum of 3 quarters · filed 2015-02-17 | $15.03M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $54.41M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $57.11M derived: sum of 2 quarters · filed 2015-02-17 | $57.94M derived: sum of 3 quarters · filed 2015-02-17 | $64.54M 10-K · filed 2015-02-17 |
| 2012-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $3.53M derived: sum of 2 quarters · filed 2013-10-31 | $10.13M 10-Q · filed 2013-10-31 | $14.08M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $7.43M 10-Q · filed 2013-08-01 | $11.38M derived: sum of 3 quarters · filed 2014-02-21 | $11.46M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $6.59M 10-Q · filed 2013-05-02 | $10.55M derived: sum of 2 quarters · filed 2014-02-21 | $10.63M derived: sum of 3 quarters · filed 2014-02-21 | -$3.57M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $4.04M derived: sum of 2 quarters · filed 2014-02-21 | -$10.16M derived: sum of 3 quarters · filed 2014-02-21 | $714.00K 10-K · filed 2014-02-21 |
| 2011-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$14.12M derived: sum of 2 quarters · filed 2012-11-01 | -$3.24M 10-Q · filed 2012-11-01 | -$2.27M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | -$14.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$3.33M 10-Q · filed 2012-08-03 | -$2.36M derived: sum of 3 quarters · filed 2013-02-21 | -$3.98M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $10.88M 10-Q · filed 2012-04-26 | $11.84M derived: sum of 2 quarters · filed 2013-02-21 | $10.22M derived: sum of 3 quarters · filed 2013-02-21 | $11.33M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $966.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$659.00K derived: sum of 2 quarters · filed 2013-02-21 | $448.00K derived: sum of 3 quarters · filed 2013-02-21 | -$157.96M 10-K · filed 2013-02-21 |
| 2010-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$518.00K derived: sum of 2 quarters · filed 2011-10-27 | -$158.93M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$157.30M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$158.41M 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $162.61M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |